Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
JIB
BioConferenceLive

MRI/NRS Technology Designed for Imaging Dense Breast Abnormalities

By BiotechDaily International staff writers
Posted on 04 Feb 2014
Image: Overview of the MRI/near-infrared spectroscopy (NIRS) system. The NIRS system is housed in the MRI control room (a) and light is piped into the MRI suite for patient imaging using fiber optic cables (b). A combined MRI/NIRS breast coil (c) makes simultaneous MRI and NIRS imaging possible (Photo courtesy of Norris Cotton Cancer Center).
Image: Overview of the MRI/near-infrared spectroscopy (NIRS) system. The NIRS system is housed in the MRI control room (a) and light is piped into the MRI suite for patient imaging using fiber optic cables (b). A combined MRI/NIRS breast coil (c) makes simultaneous MRI and NIRS imaging possible (Photo courtesy of Norris Cotton Cancer Center).
Engineers and radiologists are developing a new application for diagnostic imaging of dense breasts with suspicious lesions. The magnetic resonance imaging/near-infrared spectroscopy (MRI/NIRS) technique offers greater flexibility, speed, and accuracy than existing imaging modalities. The new technology also shows potential for enhancing MRI’s ability to differentiate cancer from benign abnormalities.

Combined MRI/NIRS may benefit women whose mammogram showed an abnormality and requires additional testing to rule out cancer. The scanning would be conducted before an invasive biopsy to search for tumors. For the new technology to perform effectively in routine patient care, MRI/NIRS must adapt to an individual’s body size as well as accommodate a range of cup sizes. The equipment must also mobilize and maintain contact with the breast.

An MRI/NIRS may provide certain advantages to women with dense breasts, who are more prone to develop and die from breast cancer. A dense breast is more difficult for a radiologist to “see through” when using standard imaging equipment, which lacks the sensitivity to penetrate the dense tissue. Conventional breast screening is effective 77%–97% of the time in a normal breast, but when a breast is dense precision falls to 63%–89%.

Earlier techniques for MRI/NIRS used parallel plates and required custom breast molds for each patient. Biomedical engineers developed a new, more flexible, convenient, and comfortable approach. They designed a set of eight light transmitting cables that can be adjusted to surround the breast with light tension. A woman lies on her stomach and the breast hangs suspended through the holes of the MRI/NIRS breast coil. The procedure is nearly the same as clinical MRI scanning.

Eight women participated in the study of this new design the findings of which were published in the February 2014 issue of Academic Radiology. “We found that the new interface allowed us to target lesions more effectively than ever before,” said Dr. Michael Mastanduno, from Geisel School of Medicine at Dartmouth University (Hanover, NH, USA) and corresponding author of the study. “Set up time was faster and images were of higher quality.”

The Dartmouth MRI/NIRS technology offers increased coverage of the chest, giving providers improved visibility for “hard to see” areas, such as the neighboring region of the breast near the armpit. “This work is a huge improvement on previous designs of MRI/NIRS systems. All breast sizes and lesion locations can now be effectively imaged. Though there is more work to be done, this technology is promising for improving MRI’s ability to distinguish cancer from benign abnormalities,” said Dr. Mastanduno.

In the next phase of the study, Dartmouth researchers will assess MRI/NIRS in women with suspicious lesions.

Related Links:

Geisel School of Medicine at Dartmouth University



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: In the liver tissue of obese animals with type II diabetes, unhealthy, fat-filled cells are prolific (small white cells, panel A). After chronic treatment through FGF1 injections, the liver cells successfully lose fat and absorb sugar from the bloodstream (small purple cells, panel B) and more closely resemble cells of normal, non-diabetic animals (Photo courtesy of the Salk Institute for Biological Studies).

Fibroblast Growth Factor 1 Treatment Restores Glucose Control in Mouse Diabetes Model

A "vaccine" based on the metabolic regulator fibroblast growth factor 1 (FGF1) removed the insulin resistance that characterizes type II diabetes and restored the body's natural ability to manage its glucose... Read more

Drug Discovery

view channel
Image: Molecular rendering of the crystal structure of parkin (Photo courtesy of Wikimedia Commons).

Cinnamon Feeding Blocks Development of Parkinson's Disease in Mouse Model

A team of neurological researchers has identified a molecular mechanism by which cinnamon acts to protect neurons from damage caused by Parkinson's disease (PD) in a mouse model of the syndrome.... Read more

Therapeutics

view channel
Image: This type of electronic pacemaker could become obsolete if induction of biological pacemaker cells by gene therapy proves successful (Photo courtesy of Wikimedia Commons).

Gene Therapy Induces Functional Pacemaker Cells in Pig Heart Failure Model

Cardiovascular disease researchers working with a porcine heart failure model have demonstrated the practicality of using gene therapy to replace implanted electronic pacemakers to regulate heartbeat.... Read more

Lab Technologies

view channel

Precise Ion Irradiation Dosing Method Developed for Cancer Therapy

Scientists are employing nuclear physics principles to provide more effective approaches to radiotherapy treatment for cancer patients. Radiation therapy using heavy ions is best suitable for cancer patients with tumors that are difficult to access, such as in the brain. These particles scarcely damage the penetrated... Read more

Business

view channel

Cancer Immunotherapy Sector Predicted to Surge to USD 9 Billion Across Major Pharma Through 2022

The immunotherapy market will experience substantial growth through 2022, increasing from USD 1.1 billion in 2012 to nearly USD 9 billion in 2022 (corresponding to 23.8% annual growth) in the United Kingdom, United States, France, Germany, Italy, Spain, and Japan, according to recent market research. This notable growth... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.